Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Rheumatoid arthritis More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Rapidly (less than 24 hours) diagnose MOTT infections in humans or animals More
A vector to be used for transfection and purification of human soluble FcRn receptor More
Portable Imaging Device for Tuberculosis Detection: Portable, Hand-Held Devices that can be used in the Clinic and in the Field More
Related Reports
Market Research Reports provided by reports.iptechex.com
May 2011 - 81 pages - $3,835
Nov 2010 - 178 pages - $1,495
Nov 2011 - 7 pages - $3,835
Nov 2010 - 160 pages - $1,495
Apr 2010 - 510 pages - $2,695
May 2011 - 5 pages - $500
Mar 2011 - 26 pages - $500
Jul 2010 - 30 pages - $750
Jun 2011 - 62 pages - $2,000
Jan 2011 - 33 pages - $500
Your selection
Browse By
- Industry sector
- Assay systems
- Diagnostic test systems
- Gene therapy
- Human diagnostics
- Human therapeutics
- Nanotechnology
- Other
- Research supplies
- Stem cells
- Therapeutic target
- Adult respiratory distress syndrome
- Allergy, respiratory
- Asthma
- Asthma, bronchospasm
- Bronchitis
- Chest disorder (other)
- Chlamydia pneumoniae
- Chronic obstructive pulmonary disease
- Cough
- Cystic fibrosis
- Dysplasia, bronchopulmonary
- Emphysema
- Granulomatous lung disease sarcoidosis
- Idiopathic respiratory distress syndrome
- Meconium aspiration syndrome
- Nasal disorder (other)
- Obstructive airway disease
- Pneumonia
- Pneumonocystis carinii lung infection
- Pseudomonas lung infection
- Respiratory disorder (other)
- Respiratory syncytial virus
- Respiratory tract infections
- Rhinitis
- Rhinovirus (common cold)
- Sinusitis
- Sleep apnea
- Throat disorder (other)
- Tuberculosis
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us